Search

The haddock model of GDP KRas in complex with promethazine using NMR chemical shift perturbations
Authors
Wang, X., Gorfe, A.A., Putkey, J.P.
Assembly
GTPase KRas (E.C.3.6.5.2)
Entity
1. GTPase KRas (E.C.3.6.5.2), entity 1 (polymer), 169 monomers, 19245.52 Da Detail

MTEYKLVVVG AGGVGKSALT IQLIQNHFVD EYDPTIEDSY RKQVVIDGET CLLDILDTAG QEEYSAMRDQ YMRTGEGFLC VFAINNTKSF EDIHHYREQI KRVKDSEDVP MVLVGNKCDL PSRTVDTKQA QDLARSYGIP FIETSAKTRQ GVDDAFYTLV REIRKHKEK


2. GTPase KRas (E.C.3.6.5.2), entity GDP (non-polymer), 443.201 Da
3. GTPase KRas (E.C.3.6.5.2), entity MG (non-polymer), 24.305 Da
4. GTPase KRas (E.C.3.6.5.2), entity ZM7 (non-polymer), 284.419 Da
Total weight
19997.445 Da
Max. entity weight
19245.52 Da
Source organism
Homo sapiens
Exptl. method
solution NMR
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 91.7 %, Completeness: 27.3 %, Completeness (bb): 61.4 % Detail

Polymer type: polypeptide(L)

Total1H15N
All27.3 % (330 of 1211)17.1 % (175 of 1023)82.4 % (155 of 188)
Backbone61.4 % (313 of 510)45.8 % (158 of 345)93.9 % (155 of 165)
Sidechain 2.4 % (17 of 701) 2.5 % (17 of 678) 0.0 % (0 of 23)
Aromatic 0.0 % (0 of 70) 0.0 % (0 of 70)
Methyl 2.1 % (2 of 95) 2.1 % (2 of 95)

1. entity 1

MTEYKLVVVG AGGVGKSALT IQLIQNHFVD EYDPTIEDSY RKQVVIDGET CLLDILDTAG QEEYSAMRDQ YMRTGEGFLC VFAINNTKSF EDIHHYREQI KRVKDSEDVP MVLVGNKCDL PSRTVDTKQA QDLARSYGIP FIETSAKTRQ GVDDAFYTLV REIRKHKEK

Sample #1

Solvent system 95% H2O/5% D2O, Pressure 1 Pa, Temperature 298 K, pH 7.4, Details 0.8 mM [U-99% 13C; U-99% 15N] GTPase KRas, 1.0 mM PMZ, 5 mM [U-99% 2H] DTT, 25 mM sodium phosphate, 50 mM sodium chloride, 10 uM [U-99% 2H] DSS, 5 mM MAGNESIUM ION, 95% H2O/5% D2O


#NameIsotope labelingTypeConcentration
1GTPase KRas[U-99% 13C; U-99% 15N]0.8 mM
2PMZnatural abundance1.0 mM
3DTT[U-99% 2H]5 mM
4sodium phosphatenatural abundance25 mM
5sodium chloridenatural abundance50 mM
6DSS[U-99% 2H]10 uM
7MAGNESIUM IONnatural abundance5 mM
Sample #2

Solvent system 100% D2O, Pressure 1 Pa, Temperature 298 K, pH 7.4, Details 0.8 mM [U-99% 13C; U-99% 15N] GTPase KRas, 1.0 mM PMZ, 5 mM [U-99% 2H] DTT, 25 mM sodium phosphate, 50 mM sodium chloride, 5 mM MAGNESIUM ION, 10 uM [U-99% 2H] DSS, 100% D2O


#NameIsotope labelingTypeConcentration
8GTPase KRas[U-99% 13C; U-99% 15N]0.8 mM
9PMZnatural abundance1.0 mM
10DTT[U-99% 2H]5 mM
11sodium phosphatenatural abundance25 mM
12sodium chloridenatural abundance50 mM
13DSS[U-99% 2H]10 uM
14MAGNESIUM IONnatural abundance5 mM

Release date
2022-05-03
Citation
Antipsychotic phenothiazine drugs bind to KRAS in vitro
Wang, X., Gorfe, A.A., Putkey, J.A.
J. Biomol. NMR (2021), 75, 233-244, PubMed 34176062 , DOI 10.1007/s10858-021-00371-z ,
Entries sharing articles BMRB: 1 entries Detail
  BMRB: 30845 released on 2021-02-14
    Title The haddock model of GDP KRas in complex with promazine using chemical shift perturbations and intermolecular NOEs
Related entities 1. GTPase KRas (E.C.3.6.5.2), entity 1, : 1 : 24 : 5 : 74 : 195 entities Detail
Interaction partners 1. GTPase KRas (E.C.3.6.5.2), entity 1, : 53 interactors Detail
Experiments performed 5 experiments Detail
Chemical shift validation 6 contents Detail
Keywords HADDOCK, HYDROLASE-HYDROLASE inhibitor complex, KRas, allosteric inhibitor, drug discovery